DIFFUSPHERE
Third Extension - Granted
Status timeline
- 30 Nov 2023Application filedNew Application Entered
- 26 Jun 2024Assigned to an examining attorneyAssigned To Examiner
- 5 Aug 2024Approved for publicationApproved For Pub - Principal Register
- 10 Sep 2024Published for oppositionPublished For Opposition
- 5 Nov 2024Notice of allowance issued — statement of use requiredNoa E-Mailed - Sou Required From Applicant
- 4 Mar 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 15 Oct 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 31 Mar 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 30 USPTO events
| 2026-08-04 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-08-04 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-08-04 | Teas Change Of Domestic Representatives Address |
| 2026-08-04 | Teas Change Of Correspondence Received |
| 2026-07-22 | Teas Withdrawal Of Attorney Received |
| 2026-07-22 | Withdrawal Of Attorney Granted |
| 2026-04-02 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-03-31 | Sou Teas Extension Received |
| 2026-03-31 | Sou Extension 3 Filed |
| 2026-03-31 | Sou Extension 3 Granted |
| 2025-10-15 | Sou Extension 2 Granted |
| 2025-10-15 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-10-14 | Sou Teas Extension Received |
| 2025-10-14 | Sou Extension 2 Filed |
| 2025-03-04 | Sou Extension 1 Granted |
| 2025-03-04 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-03-03 | Sou Teas Extension Received |
| 2025-03-03 | Sou Extension 1 Filed |
| 2024-11-05 | Noa E-Mailed - Sou Required From Applicant |
| 2024-09-10 | Published For Opposition |
| 2024-09-10 | Official Gazette Publication Confirmation E-Mailed |
| 2024-08-21 | Notification Of Notice Of Publication E-Mailed |
| 2024-08-05 | Examiners Amendment -Written |
| 2024-08-05 | Examiners Amendment E-Mailed |
| 2024-08-05 | Notification Of Examiners Amendment E-Mailed |
| 2024-08-05 | Examiner's Amendment Entered |
| 2024-08-05 | Approved For Pub - Principal Register |
| 2024-06-26 | Assigned To Examiner |
| 2024-01-18 | New Application Office Supplied Data Entered |
| 2023-11-30 | New Application Entered |
Goods & services
Class 5 Pharmaceuticals & supplements
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical drug delivery systems, namely, polymer-based drug delivery formulations being oral tablets used with various medications for sustained release of medication into the body; drug delivery formulations for medical use, namely, drug delivery agents in the form of powder and liquid that provide diffused release in the nature of controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery formulations for medical use, namely, drug delivery agents in the form of micro-thin polymer coated microspheres for sustained drug delivery
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 4 Aug 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.